Penumbra, Inc. (PEN), a medical devices manufacturer, Thursday reported that its preliminary fourth quarter revenue and full year revenue have increased around 21.4 percent to 22 percent and around 17.3 percent to 17.5 percent respectively.
Preliminary Quarterly revenue grew to the range of $383.0 million to $384.8 million and full year revenue rose to the range of $1,401.3 million to $1,403.1 million.
In pre-market activity, PEN shares were trading at $354.49, up 13.15% on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.